Biomarker indicating neurodegeneration identified in the eye

September 21, 2020

Boston - A new Alzheimer's Research & Therapy, these results set a foundation for future studies to investigate the potential of this biomarker to accelerate the diagnosis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases.

Diseases such as Alzheimer's Disease and Parkinson's Disease are the result of nerve cells in the brain or peripheral nervous system losing function over time, eventually leading to cell death. While there are treatments available to address the physical and mental symptoms associated with these progressive diseases, there are no known cures, and early treatment can help delay the progression of these diseases once they start.

"One of the biggest priorities in Alzheimer's disease research is to develop ways to diagnose the disease before the onset of symptoms, which would allow for early treatment that could help halt the progression of this fatal disease," said Manju Subramanian, MD, an ophthalmologic surgeon at Boston Medical Center and the study's first and corresponding author. Neurodegenerative diseases are currently diagnosed based on clinical presentation and diagnostic testing - once symptoms appear it means that the disease is already progressing.

Biomarkers are a major focus of neurodegenerative disease research given their promise as a way to detect the presence of a disease in earlier stages based on clues found in other parts of the body. Previous studies have established that amyloid- β and tau proteins are biomarkers for Alzheimer's disease, and they have been detected in cerebrospinal fluid, blood, and in fluid around the eye.

For this study, the researchers collected eye fluid samples from 77 patients who were undergoing previously scheduled eye surgery at Boston Medical Center. Sixty three percent of the subjects were male, and the average age was just over 56 years old. The results showed that all 77 patients had Neurofilament light chain in their vitreous humor, and higher levels of this biomarker were associated with higher levels of other biomarkers known to be associated with Alzheimer's disease, including amyloid-B and tau proteins. Neurofilament light chain levels were not significantly associated with eye disease, which means that those levels appear not to be influenced by the clinical eye conditions affecting the patients.

As the number of people living longer has increased over the previous decades, particularly in the Western world, the prevalence of neurodegenerative diseases has also increased. According to the National Institutes of Health, Alzheimer's disease and Parkinson's disease are the two most common neurodegenerative diseases, affecting approximately 5.5 million and one million Americans, respectively.

"As an extension of the brain, the eye can provide important insight about what's happening pathologically in the brain," added Subramanian, also an associate professor of ophthalmology at Boston University School of Medicine. "We hope that these results will add another way to use information about what's happening in different parts of the body to detect the presence of disease before neurodegeneration takes hold, causing irreversible damage. The earlier we can diagnose and treat these diseases, the better off our patients will be."
This study was supported in part by the National Institutes of Health's National Institute of Aging (R03AG063255).

About Boston Medical Center

Boston Medical Center (BMC) is a private, not-for-profit, 514-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. BMC offers specialized care for complex health problems and is a leading research institution, receiving more than $166 million in sponsored research funding in fiscal year 2019. It is the 13th largest funding recipient in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. Boston Medical Center and Boston University School of Medicine are partners in Boston HealthNet - 12 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit

Boston Medical Center

Related Boston Articles from Brightsurf:

VA Boston and BU researchers streamline PTSD diagnosis with machine learning
Now, researchers from the VA Boston Healthcare System and the Boston University School of Public Health (BUSPH) have used machine learning to explore streamlining the ''gold standard'' diagnostic tool for PTSD.

Zero-emissions Boston could save 288 lives and $2.4 billion annually: BU study
With much of the City of Boston shut down by COVID-19, the region is enjoying better air quality than it has seen in decades, a preview of the reduced emissions that will come as part of the city's ambitious 'Carbon Free Boston' goals.

New approach to sustainable building takes shape in Boston
A new building about to take shape in Boston's Roxbury area could, its designers hope, herald a new way of building residential structures in cities.

Boston Harbor cleanup was economically justifiable, finds new study
A first-of-its-kind retrospective study finds that environmental cleanup projects are economically viable.

Flounder now tumor-free in Boston Harbor
In the late 1980s, more than three-quarters of the winter flounder caught in Boston Harbor -- one of the most polluted harbors in America -- showed signs of liver disease, many of them with cancerous tumors.

What would it take to turn Boston harbor into tea? (video)
On December 16, 1773, the Boston tea party protestors threw more than 340 chests full of tea -- the equivalent of about 18 and a half million teabags -- into the harbor.

The truth behind St. Patrick's Day: Celebrations did NOT originate in Boston
Gun expenditure log from 1600 and 1601 prove St. Patrick's Day celebrations began in St.

Boston researcher receives global surgery award
Maunil Bhatt, M.D., a post graduate resident in the Department of Surgery at Boston University School of Medicine and Boston Medical Center (BMC), was recently honored with a Global Surgery Research Fellowship Award by the Association for Academic Surgery (AAS) at their 12th Annual Academic Conference.

New research to be highlighted at Society of NeuroInterventional Surgery Boston meeting
The Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting -- to be held July 25 - 28 in Boston -- will feature new research and best practices in improving stroke systems of care, addressing difficult stroke cases, understanding interventionalist approaches to oncology, and treating arteriovenous malformations and aneurysms, and more.

Boston subway system covered in microbes, but they're not harmful
Boston's subway system, known as the T, might be just as bacteria-laden as you'd expect but organisms found there are largely from normal human skin and incapable of causing disease, according to a study published June 28 in mSystems, an open access journal of the American Society for Microbiology.

Read More: Boston News and Boston Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to